Advertisement
The application of biofilm science to the study and control of chronic bacterial infections
William Costerton, Richard Veeh, Mark Shirtliff, Mark Pasmore, Christopher Post, Raffaella Adami, and Garth Ehrlich
Find articles by Costerton, W. in: PubMed | Google Scholar
Find articles by Veeh, R. in: PubMed | Google Scholar
Find articles by Shirtliff, M. in: PubMed | Google Scholar
Find articles by Pasmore, M. in: PubMed | Google Scholar
Find articles by Post, C. in: PubMed | Google Scholar
Find articles by Adami, R. in: PubMed | Google Scholar
Find articles by Ehrlich, G. in: PubMed | Google Scholar
Published January 2, 2007 - More info
J Clin Invest. 2007;117(1):278–278. https://doi.org/10.1172/JCI20365C1.
© 2007 The American Society for Clinical Investigation
Related article:
Abstract
Unequivocal direct observations have established that the bacteria that cause device-related and other chronic infections grow in matrix-enclosed biofilms. The diagnostic and therapeutic strategies that have served us so well in the partial eradication of acute epidemic bacterial diseases have not yielded accurate data or favorable outcomes when applied to these biofilm diseases. We discuss the potential benefits of the application of the new methods and concepts developed by biofilm science and engineering to the clinical management of infectious diseases.
Authors
William Costerton, Richard Veeh, Mark Shirtliff, Mark Pasmore, Christopher Post, Garth Ehrlich
Original citation: J. Clin. Invest.112:1466-1477 (2003). doi:10.1172/JCI200320365
Citation for this corrigendum: J. Clin. Invest.117:278 (2007). doi:10.1172/JCI20365C1
The reference citation for Figure 1A was incorrect. The correct citation appears in the statement below.
Image published with permission from the American Society for Microbiology (60).
The authors regret this error.
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)